Patents by Inventor Masaki Terahara
Masaki Terahara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10925906Abstract: An object of the present invention is to provide a brain function improving agent for neonates, especially, newborn neonates. According to the present invention, there is provided a brain function improving agent for neonates, comprising a lactic acid bacterium and/or a Bifidobacterium. The brain function improving agent or composition for improving brain function for neonates according to the present invention is advantageous in that the use thereof can improve the developmental quotient without any side effect and also enables effective development and growth of neonates.Type: GrantFiled: April 12, 2017Date of Patent: February 23, 2021Inventors: Satoshi Kusuda, Satsuki Totsu, Masaki Terahara
-
Patent number: 10517907Abstract: The present invention provides a novel anticariogenic agent without side effects so that anticariogenic effect can also be obtained in humans who are highly sensitive to oligosaccharides and sugar alcohols. Also, an agent for preventing periodontal disease or for treating periodontal disease which has an effect of preventing or treating periodontal disease and which does not have side effects is provided. The invention relates to an anticariogenic agent and an anticariogenic composition comprising a bifidobacterium, an agent and a composition for preventing periodontal disease comprising a bifidobacterium and an agent and a composition for treating periodontal disease comprising a bifidobacterium.Type: GrantFiled: March 14, 2019Date of Patent: December 31, 2019Assignee: Meiji Co., Ltd.Inventors: Masaki Terahara, Takeshi Takahashi, Hiroyuki Itou
-
Publication number: 20190240268Abstract: Provided herein is an infection protective agent for ameliorating infections in infants, particularly newborns, without causing side effects. The infection protective agent for infants of the present invention comprises a bifidobacterium.Type: ApplicationFiled: March 14, 2019Publication date: August 8, 2019Applicants: MEIJI CO., LTD., SHIGA UNIVERSITY OF MEDICAL SCIENCEInventors: Shigeki KOSHIDA, Masaki TERAHARA
-
Publication number: 20190201460Abstract: The present invention provides a novel anticariogenic agent without side effects so that anticariogenic effect can also be obtained in humans who are highly sensitive to oligosaccharides and sugar alcohols. Also, an agent for preventing periodontal disease or for treating periodontal disease which has an effect of preventing or treating periodontal disease and which does not have side effects is provided. The invention relates to an anticariogenic agent and an anticariogenic composition comprising a bifidobacterium, an agent and a composition for preventing periodontal disease comprising a bifidobacterium and an agent and a composition for treating periodontal disease comprising a bifidobacterium.Type: ApplicationFiled: March 14, 2019Publication date: July 4, 2019Applicant: Meiji Co., Ltd.Inventors: Masaki TERAHARA, Takeshi TAKAHASHI, Hiroyuki ITOU
-
Publication number: 20190201459Abstract: Provided herein is an anti-allergic agent for ameliorating an allergic disease in infants, particularly newborns, without causing side effects. The anti-allergic agent for infants comprises a bifidobacterium.Type: ApplicationFiled: March 14, 2019Publication date: July 4, 2019Applicants: Meiji Co., Ltd., SHIGA UNIVERSITY OF MEDICAL SCIENCEInventors: Shigeki Koshida, Masaki Terahara
-
Publication number: 20190134114Abstract: An object of the present invention is to provide a brain function improving agent for neonates, especially, newborn neonates. According to the present invention, there is provided a brain function improving agent for neonates, comprising a lactic acid bacterium and/or a Bifidobacterium. The brain function improving agent or composition for improving brain function for neonates according to the present invention is advantageous in that the use thereof can improve the developmental quotient without any side effect and also enables effective development and growth of neonates.Type: ApplicationFiled: April 12, 2017Publication date: May 9, 2019Applicant: Meiji Co., Ltd.Inventors: Satoshi KUSUDA, Satsuki TOTSU, Masaki TERAHARA
-
Publication number: 20180311289Abstract: Provided herein is an infection protective agent for ameliorating infections in infants, particularly newborns, without causing side effects. The infection protective agent for infants of the present invention comprises a bifidobacterium.Type: ApplicationFiled: October 19, 2016Publication date: November 1, 2018Applicants: Meiji Co., Ltd., SHIGA UNIVERSITY OF MEDICAL SCIENCEInventors: Shigeki KOSHIDA, Masaki TERAHARA
-
Publication number: 20180303883Abstract: Provided herein is an anti-allergic agent for ameliorating an allergic disease in infants, particularly newborns, without causing side effects. The anti-allergic agent for infants comprises a bifidobacterium.Type: ApplicationFiled: October 19, 2016Publication date: October 25, 2018Applicants: Meiji Co., Ltd., SHIGA UNIVERSITY OF MEDICAL SCIENCEInventors: Shigeki KOSHIDA, Masaki TERAHARA
-
Publication number: 20180071346Abstract: The present invention provides a novel anticariogenic agent without side effects so that anticariogenic effect can also be obtained in humans who are highly sensitive to oligosaccharides and sugar alcohols. Also, an agent for preventing periodontal disease or for treating periodontal disease which has an effect of preventing or treating periodontal disease and which does not have side effects is provided. The invention relates to an anticariogenic agent and an anticariogenic composition comprising a bifidobacterium, an agent and a composition for preventing periodontal disease comprising a bifidobacterium and an agent and a composition for treating periodontal disease comprising a bifidobacterium.Type: ApplicationFiled: May 24, 2016Publication date: March 15, 2018Applicant: Meiji Co., Ltd.Inventors: Masaki TERAHARA, Takeshi TAKAHASHI, Hiroyuki ITOU
-
Patent number: 9314041Abstract: A probiotic lactobacillus was discovered from lactobacilli of the Lactobacillus genus independently isolated from human adult feces.Type: GrantFiled: February 23, 2006Date of Patent: April 19, 2016Assignee: MEIJI CO., LTD.Inventors: Toshihiro Sashihara, Makoto Yamaguchi, Yoshitaka Nakamura, Shuji Ikegami, Seiko Narushima, Katsunori Kimura, Shinya Nagafuchi, Masaki Terahara
-
Patent number: 7943124Abstract: The present invention relates to a composition for immunostimulation useful for promoting IgA and secretory component productions in mucosal tissues, comprising, alone or in combination, a cell of bifidobacterium belonging to Bifidobacterium bifidum or a processed product thereof, wherein the bifidobacterium has an activity to stimulate secretory component production and a high activity to stimulate IgA production, for example, it is a Bifidobacterium bifidum OLB 6377 strain or Bifidobacterium bifidum OLB 6378 strain.Type: GrantFiled: February 1, 2006Date of Patent: May 17, 2011Assignee: Meiji Dairies CorporationInventors: Itaru Moro, Takashi Iwase, Kuniyasu Ochiai, Masako Yajima, Masaki Terahara, Yoshitaka Nakamura, Mamoru Totsuka, Kiyoshi Yamada
-
Publication number: 20090269321Abstract: A probiotic lactobacillus was discovered from lactobacilli of the Lactobacillus genus independently isolated from human adult feces.Type: ApplicationFiled: February 23, 2006Publication date: October 29, 2009Inventors: Toshihiro Sashihara, Makoto Yamaguchi, Yoshitaka Nakamura, Shuji Ikegami, Seiko Narushima, Katsunori Kimura, Shinya Nagafuchi, Masaki Terahara
-
Publication number: 20090142374Abstract: The present invention relates to a composition for immunostimulation useful for promoting IgA and secretory component productions in mucosal tissues, comprising, alone or in combination, a cell of bifidobacterium belonging to Bifidobacterium bifidum or a processed product thereof, wherein the bifidobacterium has an activity to stimulate secretory component production and a high activity to stimulate IgA production, for example, it is a Bifidobacterium bifidum OLB 6377 strain or Bifidobacterium bifidum OLB 6378 strain.Type: ApplicationFiled: February 1, 2006Publication date: June 4, 2009Applicant: MEIJI DAIRIES CORPORATIONInventors: Itaru Moro, Takashi Iwase, Kuniyasu Ochiai, Masako Yajima, Masaki Terahara, Yoshitaka Nakamura, Mamoru Totsuka, Kiyoshi Yamada